Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis

2019/10/28 by Nicola Black, Emily Stockings, Gabrielle Campbell +7 · 4 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · Psychology · #Cannabis and Cannabinoid Research #Forensic Toxicology and Drug Analysis #Psychedelics and Drug Studies

paper · doi:10.1016/s2215-0366(19)30401-8

openalex publication_date 2019/10/28 · crossref created 2019/10/28 · crossref issued 2019/12/01 · crossref published 2019/12/01 · crossref published-print 2019/12/01 · openalex created_date 2025/10/10 · crossref deposited 2025/11/06 · crossref indexed 2026/08/02 · openalex updated_date 2026/08/02

Citations

• Statistical power analysis for the behavioral sciences
• Cannabinoids for Medical Use
• Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies
• Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
• Cochrane Handbook for Systematic Reviews of Interventions

Cited by

• European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part III: pharmacological treatment
• Major depressive disorder [wikipedia]
• Mental disorder [wikipedia]
• Tourette syndrome [wikipedia]